HLA-C and neoplasm: The advantages of CAR-T cells lie in not only the recognition of specific antigens and stimulation without MHC limitation, but also their capability of generating an anti-tumor immune microenvironment featuring decreased levels of anti-inflammatory factors and increased levels of pro-inflammatory factors (132, 133).